C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $4.16 Million in iShares Biotechnology ETF (NASDAQ:IBB)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 31,475 shares of the financial services provider’s stock, valued at approximately $4,161,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Valeo Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $206,000. Prism Advisors Inc. purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $206,000. SeaCrest Wealth Management LLC raised its holdings in shares of iShares Biotechnology ETF by 203.7% during the third quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock valued at $1,487,000 after acquiring an additional 6,850 shares during the period. SPC Financial Inc. lifted its position in shares of iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after acquiring an additional 75 shares in the last quarter. Finally, Good Life Advisors LLC boosted its stake in iShares Biotechnology ETF by 59.4% in the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock worth $388,000 after purchasing an additional 993 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.9 %

NASDAQ IBB opened at $135.47 on Thursday. The firm’s 50 day moving average price is $135.88 and its two-hundred day moving average price is $141.13. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.